Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first81 to 100 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| MAPK14 mitogen-activated protein kinase 14 | 1432 HGNC:6876 | 1 | 114 | 37 | 92 | 20,334 | 61,315 |
| CTLA4 cytotoxic T-lymphocyte associated protein 4 | 1493 HGNC:2505 | 1 | 639 | 6 | 1,206 | 14,782 | 60,841 |
| CD14 CD14 molecule | 929 HGNC:1628 | 1 | 122 | 2 | 19 | 23,434 | 60,671 |
| PTGS2 prostaglandin-endoperoxide synthase 2 | 5743 HGNC:9605 | 1 | 184 | 83 | 2,123 | 13,834 | 59,073 |
| GH1 growth hormone 1 | 2688 HGNC:4261 | 1 | 271 | 0 | 0 | 12,078 | 58,824 |
| AFP alpha fetoprotein | 174 HGNC:317 | 1 | 204 | 1 | 0 | 5,642 | 58,305 |
| PTH parathyroid hormone | 5741 HGNC:9606 | 1 | 127 | 0 | 0 | 7,792 | 57,840 |
| TRBV20OR9-2 T cell receptor beta variable 20/OR9-2 (non-functional) | 6962 HGNC:12197 | 0 | 0 | 0 | 0 | 20,044 | 57,249 |
| ABCB1 ATP binding cassette subfamily B member 1 | 5243 HGNC:40 | 1 | 56 | 5 | 24 | 11,552 | 57,214 |
| PPARG peroxisome proliferator activated receptor gamma | 5468 HGNC:9236 | 1 | 119 | 40 | 721 | 17,382 | 57,202 |
| POMC proopiomelanocortin | 5443 HGNC:9201 | 1 | 164 | 0 | 0 | 12,181 | 56,815 |
| ICAM1 intercellular adhesion molecule 1 | 3383 HGNC:5344 | 1 | 211 | 5 | 8 | 18,778 | 56,622 |
| KLK3 kallikrein related peptidase 3 | 354 HGNC:6364 | 1 | 337 | 1 | 0 | 9,390 | 56,437 |
| MAP2K7 mitogen-activated protein kinase kinase 7 | 5609 HGNC:6847 | 1 | 32 | 0 | 0 | 18,330 | 56,434 |
| CD44 CD44 molecule (IN blood group) | 960 HGNC:1681 | 1 | 200 | 3 | 4 | 19,189 | 56,341 |
| KIT KIT proto-oncogene, receptor tyrosine kinase | 3815 HGNC:6342 | 1 | 266 | 38 | 2,995 | 14,655 | 54,814 |
| PARP1 poly(ADP-ribose) polymerase 1 | 142 HGNC:270 | 1 | 79 | 14 | 820 | 15,744 | 54,665 |
| CYCS cytochrome c, somatic | 54205 HGNC:19986 | 1 | 135 | 0 | 0 | 15,152 | 53,992 |
| KDR kinase insert domain receptor | 3791 HGNC:6307 | 1 | 432 | 84 | 4,298 | 15,010 | 53,720 |
| ACE2 angiotensin converting enzyme 2 | 59272 HGNC:13557 | 1 | 246 | 0 | 0 | 8,956 | 53,694 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=5
{
"data": {
"total": 193990,
"results": [
{
"id": "1432",
"title": "MAPK14: mitogen-activated protein kinase 14",
"summary": "NCBI Gene 1432. 1 protein, 114 patents, 37 drugs, 92 trials, 20,334 NIH grants and 61,315 papers.",
"record": "/library/genes/1432",
"gene_id": 1432,
"symbol": "MAPK14",
"name": "mitogen-activated protein kinase 14",
"hgnc_id": "HGNC:6876",
"counts": {
"proteins": 1,
"patents": 114,
"drugs": 37,
"trials": 92,
"grants": 20334,
"papers": 61315
}
},
{
"id": "1493",
"title": "CTLA4: cytotoxic T-lymphocyte associated protein 4",
"summary": "NCBI Gene 1493. 1 protein, 639 patents, 6 drugs, 1,206 trials, 14,782 NIH grants and 60,841 papers.",
"record": "/library/genes/1493",
"gene_id": 1493,
"symbol": "CTLA4",
"name": "cytotoxic T-lymphocyte associated protein 4",
"hgnc_id": "HGNC:2505",
"counts": {
"proteins": 1,
"patents": 639,
"drugs": 6,
"trials": 1206,
"grants": 14782,
"papers": 60841
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=6",
"request_id": "w9JzGH4pEt7LPQEz"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant